SOURCE: Calabrian Corporation

July 21, 2014 11:40 ET

Calabrian Strengthens and Expands Capacity, Positioning for Future Growth

KINGWOOD, TX--(Marketwired - Jul 21, 2014) - Calabrian Corporation, the largest prime producer of liquid sulfur dioxide and related derivatives in North America, announced today that it will expand by 50% the production of SO2 at the Port Neches, Texas plant. The multimillion dollar expansion is expected to be online by the end of the year.

The expansion utilizes Calabrian's proprietary SO2CLEAN technology. The technology, which burns sulfur in pure oxygen, enables production that is highly reliable, free of SOX and NOX emissions and expandable on a modular basis, and is therefore economically superior to a sulfur burner. These characteristics speed permitting, allow rapid expansion, and make SO2CLEAN ideal for in situ production.

The driver behind the expansion is Calabrian's strategy of strengthening its leading position in SO2 and derivatives. "We view this proactive step as an investment in our customers and the industries we serve," said Randy Owens, President and CEO. "We are excited about this capacity expansion. It will allow Calabrian to achieve growth targets in applications such as water treatment, oil and gas, and mining."

ABOUT CALABRIAN CORPORATION
Calabrian Corporation is a leading supplier of sulfur dioxide and related derivatives used in wastewater treatment and other applications. The company manufactures sulfur dioxide and downstream derivatives such as sodium bisulfite solution, sodium metabisulfite, sodium thiosulfate, and sodium sulfite solution. Its products are used in a broad range of industrial and municipal wastewater treatment applications to achieve compliance with federal and local water regulations, as well as other specialty applications in personal care, pulp and paper processing, food preservation, oilfield production, mining, and disinfection. For more information please visit www.calabriancorp.com.

ABOUT SK CAPITAL PARTNERS
Calabrian Corporation is a portfolio company of SK Capital Partners. SK Capital Partners is a private investment firm with a disciplined focus on the specialty materials, chemicals, and healthcare sectors. The firm utilizes its industry, operating, and investment experience to help transform businesses into higher performing organizations. Headquartered in New York, NY, SK Capital's portfolio companies generate revenues of approximately$6.5 billion annually and employ more than 8,700 people. For more information please visit www.skcapitalpartners.com.

Contact Information